Literature DB >> 17666244

The effect of dexmedetomidine on middle ear pressure.

Yezdan Firat1, Ahmet Kizilay, Mustafa Akarcay, Aytac Yucel, Kadir But, Saim Yologlu.   

Abstract

OBJECTIVE: Dexmedetomidine is a preferred anesthetic agent in otological surgery because it provides controlled hypotension and good surgical field visibility. The aim of this study was to evaluate the influence of this novel agent on middle ear pressure. STUDY DESIGN AND
SETTING: This prospective clinical trial was performed in 60 patients who were scheduled for elective surgery. They received dexmedetomidine or saline infusion for 20 minutes before induction of anesthesia. Tympanometric measurements were recorded for both ears at preoperative, intraoperative, and postoperative states.
RESULTS: Mean difference of tympanometric peak pressure from baseline was statistically significant between dexmedetomidine and control group at the 30th minute of operation (24.8 daPa, P = 0.003 for right ear; 20.5 daPa, P = 0.02 for left ear) and at the end of the operation (25.8 daPa, P = 0.01 for right ear; 28.1 daPa, P = 0.004 for left ear).
CONCLUSIONS: Dexmedetomidine anesthesia raises the tympanometric parameters, but they never exceed the limits of normal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666244     DOI: 10.1016/j.otohns.2007.03.005

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  Dexmedetomidine infusion during middle ear surgery under general anaesthesia to provide oligaemic surgical field: A prospective study.

Authors:  Kumkum Gupta; Manoranjan Bansal; Prashant K Gupta; Mn Pandey; Salony Agarwal
Journal:  Indian J Anaesth       Date:  2015-01

2.  Different effects of propofol and isoflurane on cochlear blood flow and hearing function in Guinea pigs.

Authors:  Ying Xiao; Jian Wen; Yanxia Bai; Na Duan; G X Jing
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.